Trial intelligence / Profile preview

Lymphomyosot for Posttraumatic Edema in Ankle Fracture

NCT00884988Phase 2Suspended

Sponsor
Shaare Zedek Medical Center
Start
Feb 2010
Primary completion
Dec 2012
Modality
Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in edema comparing Lymphomyosot with Placebo (2 arms). Primary endpoint: Time from fracture to ORIF surgery at 3 weeks. Started Feb 2010; status: suspended.

02

Drugs

Lymphomyosot
03

Conditions

edema

Beyond the preview

Go deeper on NCT00884988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00884988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call